Literature DB >> 12660132

[Interferon : antiviral mechanisms and viral escape].

Lucile Espert1, Céline Gongora, Nadir Mechti.   

Abstract

15 % of human cancers have virus origin, meaning that viruses are the second cause of cancers after tabagism. The knowledge of antiviral mechanisms is essential for treatment and prevention of infection evolution towards cancers. Interferons (IFNs) are a large family of multifunctional cytokines. They are involved in regulation of cell growth and modulation of immune response. But, all these functions seem to converge toward the most important of them : the antiviral activity. IFN secretion is the first event induced by viral infection, and will act on specific receptors on neighbour cells and prevent their infection by inducing numbers of antiviral genes. Although few of them are well known like the PKR, the 2-5OAS/RNase L pathway and the Mx proteins, many others need extensive studies to understand the wide range of IFN effect. Viruses have evolved to circumvent the IFN antiviral activity, and are able not only to divert the cellular machinery but also to lure the antiviral mechanisms of the host cell. The purpose of this review is to describe the many antiviral pathways and proteins induced by IFNs and to summarize the strategies of viral escape.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12660132

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


  2 in total

1.  Alpha/beta interferon inhibits cap-dependent translation of viral but not cellular mRNA by a PKR-independent mechanism.

Authors:  Mulu Z Tesfay; Jun Yin; Christina L Gardner; Mikhail V Khoretonenko; Nadejda L Korneeva; Robert E Rhoads; Kate D Ryman; William B Klimstra
Journal:  J Virol       Date:  2007-12-26       Impact factor: 5.103

2.  Identification and characterization of interferon-induced proteins that inhibit alphavirus replication.

Authors:  Yugen Zhang; Crystal W Burke; Kate D Ryman; William B Klimstra
Journal:  J Virol       Date:  2007-08-08       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.